376 related articles for article (PubMed ID: 21099113)
1. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.
Grinberg-Bleyer Y; Saadoun D; Baeyens A; Billiard F; Goldstein JD; Grégoire S; Martin GH; Elhage R; Derian N; Carpentier W; Marodon G; Klatzmann D; Piaggio E; Salomon BL
J Clin Invest; 2010 Dec; 120(12):4558-68. PubMed ID: 21099113
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
3. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
Tonkin DR; He J; Barbour G; Haskins K
J Immunol; 2008 Oct; 181(7):4516-22. PubMed ID: 18802054
[TBL] [Abstract][Full Text] [Related]
5. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
6. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
[TBL] [Abstract][Full Text] [Related]
7. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.
Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA
Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163
[TBL] [Abstract][Full Text] [Related]
8. Can TNF-α boost regulatory T cells?
Bilate AM; Lafaille JJ
J Clin Invest; 2010 Dec; 120(12):4190-2. PubMed ID: 21099102
[TBL] [Abstract][Full Text] [Related]
9. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
10. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
[TBL] [Abstract][Full Text] [Related]
11. Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.
Jaberi-Douraki M; Pietropaolo M; Khadra A
J Theor Biol; 2015 Oct; 383():93-105. PubMed ID: 26271890
[TBL] [Abstract][Full Text] [Related]
12. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
[TBL] [Abstract][Full Text] [Related]
13. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
Manirarora JN; Wei CH
J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
[TBL] [Abstract][Full Text] [Related]
14. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
15. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
[TBL] [Abstract][Full Text] [Related]
16. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
17. Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice.
Lu Y; Suzuki J; Guillioli M; Umland O; Chen Z
Immunology; 2011 Sep; 134(1):50-9. PubMed ID: 21711461
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
Bresson D; Fousteri G; Manenkova Y; Croft M; von Herrath M
J Autoimmun; 2011 Dec; 37(4):342-51. PubMed ID: 22063316
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
20. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.
Tang Q; Adams JY; Penaranda C; Melli K; Piaggio E; Sgouroudis E; Piccirillo CA; Salomon BL; Bluestone JA
Immunity; 2008 May; 28(5):687-97. PubMed ID: 18468463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]